| Literature DB >> 23687431 |
Jian-Huan Chen1, Yunli Yang, Yuqian Zheng, Minghui Qiu, Mingliang Xie, Wenjie Lin, Mingzhi Zhang, Chi Pui Pang, Haoyu Chen.
Abstract
PURPOSE: Single nucleotide polymorphisms (SNPs) of age-related maculopathy susceptibility protein 2/HtrA serine peptidase 1 (ARMS2/HTRA1) and complement factor H (CFH) have been reported to be associated with age-related macular degeneration (AMD). The purpose of this study was to investigate the association of ARMS2/HTRA1 and CFH SNPs with early age-related maculopathy (ARM) in a Han Chinese cohort.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23687431 PMCID: PMC3654849
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Demographic and clinical features of the study subjects
| Group | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1/2/3 | |||||||||
| Control | 157 | 51/106 | 50–86 | 60 | 61.7±9.2 | 40/114 | 37/120 | - | - |
| ARM | 158 | 39/119 | 50–80 | 60 | 61.6±8.2 | 31/123 | 24/133 | 47/111 | 73/72/13 |
ARM: age-related maculopathy; AREDS: Age Related Eye Diseases Study; SD: standard deviation
Figure 1Linkage disequilibrium of age-related maculopathy susceptibility protein 2/HtrA serine peptidase 1 and complement factor H single nucleotide polymorphisms. A: The single nucleotide polymorphisms (SNPs) rs10490924, rs11200638, and rs2672598 in age-related maculopathy susceptibility protein 2/HtrA serine peptidase 1 (ARMS2/HTRA1) form a haplotype block in a 6 kb genomic region. (B) The SNPs rs10490924, rs11200638, and rs2672598 in complement factor H (CFH) form a long haplotype block in a 26 kb genomic region according to the criteria of the confidence intervals, an algorithm proposed by Gabriel et al. [20]. The solid line with an arrow indicates the transcription direction.
Association of ARMS2/HTRA1 SNPs with early ARM
| SNP | Genotype | Frequency | Association | ||||
|---|---|---|---|---|---|---|---|
| Control | ARM | OR | |||||
| N | % | N | % | (95% CI) | |||
| CC | 125 | 79.6 | 131 | 82.9 | 0.90 | 0.773 | |
| CT | 30 | 19.1 | 23 | 14.6 | (0.53 - 1.5) | ||
| TT | 2 | 1.3 | 4 | 2.5 | |||
| C | 280 | 89.2 | 285 | 90.2 | |||
| T | 34 | 10.8 | 31 | 9.8 | |||
| GG | 60 | 38.2 | 60 | 38 | 1.12 | 0.553 | |
| GT | 78 | 49.7 | 71 | 44.9 | (0.81 - 1.54) | ||
| TT | 19 | 12.1 | 27 | 17.1 | |||
| G | 198 | 63.1 | 191 | 60.4 | |||
| T | 116 | 36.9 | 125 | 39.6 | |||
| GG | 59 | 37.6 | 56 | 35.4 | 1.14 | 0.453 | |
| AG | 77 | 49 | 74 | 46.8 | (0.83 - 1.58) | ||
| AA | 21 | 13.4 | 28 | 17.7 | |||
| G | 195 | 62.1 | 186 | 58.9 | |||
| A | 119 | 37.9 | 130 | 41.1 | |||
| TT | 72 | 45.9 | 81 | 51.3 | 0.88 | 0.511 | |
| CT | 69 | 43.9 | 61 | 38.6 | (0.63 - 1.23) | ||
| CC | 16 | 10.2 | 16 | 10.1 | |||
| T | 213 | 67.8 | 223 | 70.6 | |||
| C | 101 | 32.2 | 93 | 29.4 | |||
The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; OR: odds ratio; CI: confidence interval.
Association of Complement factor H SNPs with early ARM
| SNP | Genotype | Frequency | Association | ||||
|---|---|---|---|---|---|---|---|
| Control | ARM | OR | |||||
| N | % | N | % | (95% CI) | |||
| TT | 49 | 31.2 | 51 | 32.3 | 1.04 | 0.868 | |
| TC | 74 | 47.1 | 68 | 43 | 0.76 - 1.42 | ||
| CC | 34 | 21.7 | 39 | 24.7 | |||
| T | 172 | 54.8 | 170 | 53.8 | |||
| C | 142 | 45.2 | 146 | 46.2 | |||
| GG | 51 | 32.5 | 55 | 34.8 | 1.08 | 0.680 | |
| GA | 79 | 50.3 | 66 | 41.8 | 0.79 - 1.48 | ||
| AA | 27 | 17.2 | 37 | 23.4 | |||
| G | 181 | 57.6 | 176 | 55.7 | |||
| A | 133 | 42.4 | 140 | 44.3 | |||
| CC | 144 | 91.7 | 146 | 92.4 | 0.91 | 0.987 | |
| CT | 13 | 8.3 | 12 | 7.6 | 0.4 - 2.07 | ||
| TT | 0 | 0 | 0 | 0 | |||
| C | 301 | 95.9 | 304 | 96.2 | |||
| T | 13 | 4.1 | 12 | 3.8 | |||
| CC | 49 | 31.2 | 48 | 30.4 | 1.17 | 0.372 | |
| CT | 84 | 53.5 | 75 | 47.5 | 0.85 - 1.6 | ||
| TT | 24 | 15.3 | 35 | 22.2 | |||
| C | 182 | 58 | 171 | 54.1 | |||
| T | 132 | 42 | 145 | 45.9 | |||
| GG | 39 | 24.8 | 42 | 26.6 | 1.09 | 0.632 | |
| AG | 83 | 52.9 | 71 | 44.9 | 0.8 - 1.49 | ||
| AA | 35 | 22.3 | 45 | 28.5 | |||
| G | 161 | 51.3 | 155 | 49.1 | |||
| A | 153 | 48.7 | 161 | 50.9 | |||
| TT | 39 | 24.8 | 41 | 25.9 | 1.08 | 0.690 | |
| GT | 82 | 52.2 | 73 | 46.2 | 0.79 - 1.48 | ||
| GG | 36 | 22.9 | 44 | 27.8 | |||
| T | 160 | 51 | 155 | 49.1 | |||
| G | 154 | 49 | 161 | 50.9 | |||
The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; OR: odds ratio; CI: confidence interval.
Association of ARMS2/HTRA1 SNPs with unilateral and bilateral early ARM
| Genotype frequency | Genotype frequency | Association | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CON | Unilateral
ARM | Bilateral
ARM | Unilateral
ARM | Bilateral
ARM | ||||||
| N | % | N | % | N | % | OR(95% CI) | OR(95% CI) | |||
| CC | 125 | 79.6 | 39 | 83 | 92 | 82.9 | 0.78 | 0.538 | 0.94 | 0.809 |
| CT | 30 | 19.1 | 8 | 17 | 15 | 13.5 | (0.32 - 1.67) | (0.54 - 1.59) | ||
| TT | 2 | 1.3 | 0 | 0 | 4 | 3.6 | ||||
| GG | 60 | 38.2 | 21 | 44.7 | 39 | 35.1 | 0.98 | 0.931 | 1.22 | 0.277 |
| GT | 78 | 49.7 | 18 | 38.3 | 53 | 47.7 | (0.6 - 1.58) | (0.85 - 1.76) | ||
| TT | 19 | 12.1 | 8 | 17 | 19 | 17.1 | ||||
| GG | 59 | 37.6 | 20 | 42.6 | 36 | 32.4 | 1.03 | 0.898 | 1.24 | 0.249 |
| AG | 77 | 49 | 18 | 38.3 | 56 | 50.5 | (0.64 - 1.65) | (0.86 - 1.78) | ||
| AA | 21 | 13.4 | 9 | 19.1 | 19 | 17.1 | ||||
| TT | 72 | 45.9 | 23 | 48.9 | 58 | 52.3 | 0.88 | 0.622 | 0.86 | 0.429 |
| CT | 69 | 43.9 | 20 | 42.6 | 41 | 36.9 | (0.52 - 1.45) | (0.59 - 1.24) | ||
| CC | 16 | 10.2 | 4 | 8.5 | 12 | 10.8 | ||||
The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; OR: odds ratio; CI: confidence interval.
Association of Complement facor H SNPs with unilateral and bilateral early ARM
| Genotype frequency | Genotype frequency | Association | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CON | Unilateral
ARM | Bilateral
ARM | Unilateral
ARM | Bilateral
ARM | ||||||
| N | % | N | % | N | % | OR(95% CI) | OR(95% CI) | |||
| TT | 49 | 31.2 | 17 | 36.2 | 34 | 30.6 | 0.95 | 0.835 | 1.07 | 0.712 |
| TC | 74 | 47.1 | 19 | 40.4 | 49 | 44.1 | (0.6 - 1.5) | (0.76 - 1.49) | ||
| CC | 34 | 21.7 | 11 | 23.4 | 28 | 25.2 | ||||
| GG | 51 | 32.5 | 17 | 36.2 | 38 | 34.2 | 1.01 | 0.966 | 1.07 | 0.684 |
| GA | 79 | 50.3 | 20 | 42.6 | 46 | 41.4 | (0.63 - 1.61) | (0.76 - 1.51) | ||
| AA | 27 | 17.2 | 10 | 21.3 | 27 | 24.3 | ||||
| CC | 144 | 91.7 | 44 | 93.6 | 102 | 91.9 | 0.78 | 0.709 | 0.99 | 0.989 |
| CT | 13 | 8.3 | 3 | 6.4 | 9 | 8.1 | (0.17 - 2.57) | (0.39 - 2.41) | ||
| TT | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| CC | 49 | 31.2 | 16 | 34 | 32 | 28.8 | 1.09 | 0.721 | 1.19 | 0.348 |
| CT | 84 | 53.5 | 21 | 44.7 | 54 | 48.6 | (0.67 - 1.78) | (0.83 - 1.7) | ||
| TT | 24 | 15.3 | 10 | 21.3 | 25 | 22.5 | ||||
| GG | 39 | 24.8 | 14 | 29.8 | 28 | 25.2 | 1.07 | 0.777 | 1.09 | 0.632 |
| AG | 83 | 52.9 | 19 | 40.4 | 52 | 46.8 | (0.67 - 1.71) | (0.77 - 1.55) | ||
| AA | 35 | 22.3 | 14 | 29.8 | 31 | 27.9 | ||||
| TT | 39 | 24.8 | 14 | 29.8 | 27 | 24.3 | 1.06 | 0.817 | 1.09 | 0.644 |
| GT | 82 | 52.2 | 19 | 40.4 | 54 | 48.6 | (0.66 - 1.68) | (0.77 - 1.54) | ||
| GG | 36 | 22.9 | 14 | 29.8 | 30 | 27 | ||||
The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; OR: odds ratio; CI: confidence interval.
Association of ARMS2/HTRA1 SNPs with AREDS grading of early ARM
| SNP | Genotype frequency | Association | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genotype | CON | ARM
Grade 1 | ARM
Grade 2 | ARM
Grade 3 | ARM
Grade 1 | ARM
Grade 2 | ARM
Grade 3 | ||||||||
| N | % | N | % | N | % | N | % | OR (95%CI) | OR (95%CI) | OR (95%CI) | |||||
| CC | 125 | 79.6 | 60 | 82.2 | 60 | 83.3 | 11 | 84.6 | 0.94 | 0.858 | 0.89 | 0.727 | 0.70 | 0.641 | |
| CT | 30 | 19.1 | 11 | 15.1 | 10 | 13.9 | 2 | 15.4 | (0.49 - 1.74) | (0.46 - 1.66) | (0.11 - 2.51 | ||||
| TT | 2 | 1.3 | 2 | 2.7 | 2 | 2.8 | 0 | 0 | |||||||
| GG | 60 | 38.2 | 29 | 39.7 | 26 | 36.1 | 5 | 38.5 | 1.1 | 0.645 | 1.17 | 0.466 | 1.11 | 0.819 | |
| GT | 78 | 49.7 | 31 | 42.5 | 34 | 47.2 | 6 | 46.2 | (0.73 - 1.67) | (0.77 - 1.77) | (0.46 - 2.6 | ||||
| TT | 19 | 12.1 | 13 | 17.8 | 12 | 16.7 | 2 | 15.4 | |||||||
| GG | 59 | 37.6 | 27 | 37 | 24 | 33.3 | 5 | 38.5 | 1.14 | 0.539 | 1.19 | 0.414 | 1.07 | 0.877 | |
| AG | 77 | 49 | 32 | 43.8 | 36 | 50 | 6 | 46.2 | (0.75 - 1.71) | (0.78 - 1.8) | (0.44 - 2.49) | ||||
| AA | 21 | 13.4 | 14 | 19.2 | 12 | 16.7 | 2 | 15.4 | |||||||
| TT | 72 | 45.9 | 37 | 50.7 | 39 | 54.2 | 5 | 38.5 | 0.93 | 0.751 | 0.75 | 0.205 | 1.27 | 0.565 | |
| CT | 69 | 43.9 | 27 | 37 | 28 | 38.9 | 6 | 46.2 | (0.61 - 1.42) | (0.48 - 1.16) | (0.54 - 2.89) | ||||
| CC | 16 | 10.2 | 9 | 12.3 | 5 | 6.9 | 2 | 15.4 | |||||||
The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; AREDS: Age related eye diseases study; OR: odds ratio; CI: confidence interval.
Association of Complement factor H SNPs with AREDS grading of early ARM
| SNP | Genotype Frequency | Association | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genotype | CON | ARM
Grade 1 | ARM
Grade 2 | ARM
Grade 3 | ARM
Grade 1 | ARM
Grade 2 | ARM
Grade 3 | ||||||||
| N | % | N | % | N | % | N | % | OR (95%CI) | OR (95%CI) | OR (95%CI) | |||||
| TT | 49 | 31.2 | 20 | 27.4 | 26 | 36.1 | 5 | 38.5 | 1.22 | 0.312 | 0.85 | 0.415 | 1.07 | 0.863 | |
| TC | 74 | 47.1 | 31 | 42.5 | 33 | 45.8 | 4 | 30.8 | (0.83 - 1.8) | (0.57 - 1.25) | (0.48 - 2.35) | ||||
| CC | 34 | 21.7 | 22 | 30.1 | 13 | 18.1 | 4 | 30.8 | |||||||
| GG | 51 | 32.5 | 21 | 28.8 | 28 | 38.9 | 6 | 46.2 | 1.22 | 0.328 | 0.91 | 0.641 | 1.02 | 0.963 | |
| GA | 79 | 50.3 | 33 | 45.2 | 30 | 41.7 | 3 | 23.1 | (0.82 - 1.83) | (0.61 - 1.35) | (0.44 - 2.29) | ||||
| AA | 27 | 17.2 | 19 | 26 | 14 | 19.4 | 4 | 30.8 | |||||||
| CC | 144 | 91.7 | 65 | 89 | 69 | 95.8 | 12 | 92.3 | 1.43 | 0.453 | 0.5 | 0.29 | 0.96 | 0.969 | |
| CT | 13 | 8.3 | 8 | 11 | 3 | 4.2 | 1 | 7.7 | (0.54 - 3.62) | (0.11 - 1.61) | (0.05 - 5.58) | ||||
| TT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| CC | 49 | 31.2 | 18 | 24.7 | 25 | 34.7 | 5 | 38.5 | 1.39 | 0.125 | 1.01 | 0.958 | 0.9 | 0.807 | |
| CT | 84 | 53.5 | 36 | 49.3 | 33 | 45.8 | 6 | 46.2 | (0.92 - 2.11) | (0.67 - 1.53) | (0.36 - 2.12) | ||||
| TT | 24 | 15.3 | 19 | 26 | 14 | 19.4 | 2 | 15.4 | |||||||
| GG | 39 | 24.8 | 15 | 20.5 | 22 | 30.6 | 5 | 38.5 | 1.37 | 0.125 | 0.89 | 0.556 | 0.92 | 0.84 | |
| AG | 83 | 52.9 | 33 | 45.2 | 34 | 47.2 | 4 | 30.8 | (0.92 - 2.08) | (0.59 - 1.32) | (0.4 - 2.09) | ||||
| AA | 35 | 22.3 | 25 | 34.2 | 16 | 22.2 | 4 | 30.8 | |||||||
| TT | 39 | 24.8 | 15 | 20.5 | 21 | 29.2 | 5 | 38.5 | 1.37 | 0.129 | 0.9 | 0.624 | 0.76 | 0.524 | |
| GT | 82 | 52.2 | 33 | 45.2 | 35 | 48.6 | 5 | 38.5 | (0.92 - 2.06) | (0.6 - 1.35) | (0.32 - 1.74) | ||||
| GG | 36 | 22.9 | 25 | 34.2 | 16 | 22.2 | 3 | 23.1 | |||||||
The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; AREDS: Age related eye diseases study; OR: odds ratio; CI: confidence interval.